- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 231/42 - Benzène-sulfonamido-pyrazoles
Détention brevets de la classe C07D 231/42
Brevets de cette classe: 54
Historique des publications depuis 10 ans
|
2
|
4
|
3
|
2
|
1
|
7
|
2
|
1
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| ChemoCentryx, Inc. | 361 |
6 |
| Biofront Ltd. (Cayman) | 17 |
4 |
| Dompé Farmaceutici S.p.A. | 298 |
3 |
| The Penn State Research Foundation | 1608 |
3 |
| Hoffmann-La Roche Inc. | 3783 |
2 |
| Board of Regents, The University of Texas System | 6102 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2292 |
2 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 22 |
2 |
| Sanford-Burnham Medical Research Institute | 125 |
2 |
| University of Dundee | 218 |
2 |
| Shanghai Yidi Biotechnology Co., Ltd. | 10 |
2 |
| Biofront Ltd | 9 |
2 |
| F. Hoffmann-La Roche AG | 7836 |
1 |
| Novartis Pharma AG | 226 |
1 |
| The Regents of the University of California | 20720 |
1 |
| Genentech, Inc. | 4099 |
1 |
| Bayer Cropscience AG | 1846 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 776 |
1 |
| Vertex Pharmaceuticals Incorporated | 1584 |
1 |
| Autres propriétaires | 13 |